Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Clinical Pharmacology

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: A prospective cohort study

BMJ Open | Sep 15, 2017 Clinical Pharmacology

Proton pump inhibitor use is associated with a reduced risk of infection with intestinal protozoa

Wilderness & Environmental Medicine | Sep 15, 2017 Clinical Pharmacology

Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients

Infection and Drug Resistance | Sep 15, 2017 Clinical Pharmacology

Durvalumab after chemoradiotherapy in stage III nonâsmall-cell lung cancer

New England Journal of Medicine | Sep 14, 2017 Clinical Pharmacology

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: A randomised, double-blind, multicentre, phase 3, non-inferiority trial

The Lancet | Sep 14, 2017 Clinical Pharmacology

Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: A randomized clinical trial

JAMA Neurology | Sep 14, 2017 Clinical Pharmacology

Glitazone use associated with reduced risk of Parkinson's disease

Movement Disorders | Sep 14, 2017 Clinical Pharmacology

Clinical relevance of metronidazole and peripheral neuropathy: A systematic review of the literature

International Journal of Antimicrobial Agents | Evidence based | Sep 14, 2017 Clinical Pharmacology

Randomized clinical trial: The impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy

European Journal of Gastroenterology & Hepatology | Sep 14, 2017 Clinical Pharmacology

Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis: Results of a real-life cohort

European Journal of Gastroenterology & Hepatology | Sep 14, 2017 Clinical Pharmacology

« Prev 1 … 318 319 320 321 322 … 338 Next »

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: A prospective cohort study

Proton pump inhibitor use is associated with a reduced risk of infection with intestinal protozoa

Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients

Durvalumab after chemoradiotherapy in stage III nonâsmall-cell lung cancer

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: A randomised, double-blind, multicentre, phase 3, non-inferiority trial

Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: A randomized clinical trial

Glitazone use associated with reduced risk of Parkinson's disease

Clinical relevance of metronidazole and peripheral neuropathy: A systematic review of the literature

Randomized clinical trial: The impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy

Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis: Results of a real-life cohort

Alternative Therapies and Infection Management

Age Related Macular Degeneration

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Recent Advances in Storage Media for Avulsed Tooth

MIP: Nutrition and Pharmacology: Interactions, Side Effects, and Patient Education

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: A prospective cohort study

Proton pump inhibitor use is associated with a reduced risk of infection with intestinal protozoa

Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients

Durvalumab after chemoradiotherapy in stage III nonâsmall-cell lung cancer

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: A randomised, double-blind, multicentre, phase 3, non-inferiority trial

Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: A randomized clinical trial

Glitazone use associated with reduced risk of Parkinson's disease

Clinical relevance of metronidazole and peripheral neuropathy: A systematic review of the literature

Randomized clinical trial: The impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy

Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis: Results of a real-life cohort

Alternative Therapies and Infection Management

Age Related Macular Degeneration

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Recent Advances in Storage Media for Avulsed Tooth

MIP: Nutrition and Pharmacology: Interactions, Side Effects, and Patient Education

Select Specialty

Select Topic

Durvalumab after chemoradiotherapy in stage III nonâsmall-cell lung cancer